Silence Therapeutics Statistics
Total Valuation
SLN has a market cap or net worth of $1.02 billion. The enterprise value is $968.37 million.
| Market Cap | 1.02B |
| Enterprise Value | 968.37M |
Important Dates
The next estimated earnings date is Tuesday, May 14, 2024, before market open.
| Earnings Date | May 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SLN has 46.50 million shares outstanding. The number of shares has increased by 7.74% in one year.
| Shares Outstanding | 46.50M |
| Shares Change (YoY) | +7.74% |
| Shares Change (QoQ) | +6.93% |
| Owned by Insiders (%) | 16.99% |
| Owned by Institutions (%) | 45.88% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 32.24 |
| Forward PS | n/a |
| PB Ratio | 48.56 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 30.15 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.56, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.56 |
| Quick Ratio | 3.05 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -22.38 |
Financial Efficiency
Return on equity (ROE) is -262.60% and return on invested capital (ROIC) is -286.36%.
| Return on Equity (ROE) | -262.60% |
| Return on Assets (ROA) | -47.00% |
| Return on Capital (ROIC) | -286.36% |
| Revenue Per Employee | $294,681 |
| Profits Per Employee | -$502,462 |
| Employee Count | 109 |
| Asset Turnover | 0.28 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -8.81M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +383.08% in the last 52 weeks. The beta is 1.40, so SLN's price volatility has been higher than the market average.
| Beta (1Y) | 1.40 |
| 52-Week Price Change | +383.08% |
| 50-Day Moving Average | 23.05 |
| 200-Day Moving Average | 14.30 |
| Relative Strength Index (RSI) | 51.08 |
| Average Volume (30 Days) | 234,604 |
Short Selling Information
| Short Interest | 162,012 |
| Short Previous Month | 92,658 |
| Short % of Shares Out | 0.35% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.93 |
Income Statement
In the last 12 months, SLN had revenue of $32.12 million and -$54.77 million in losses. Loss per share was -$1.44.
| Revenue | 32.12M |
| Gross Profit | 18.83M |
| Operating Income | -62.04M |
| Pretax Income | -62.93M |
| Net Income | -54.77M |
| EBITDA | -59.66M |
| EBIT | -60.23M |
| Loss Per Share | -$1.44 |
Balance Sheet
The company has $67.58 million in cash and $340,209 in debt, giving a net cash position of $67.24 million or $1.45 per share.
| Cash & Cash Equivalents | 67.58M |
| Total Debt | 340,209 |
| Net Cash | 67.24M |
| Net Cash Per Share | $1.45 |
| Equity / Book Value | 21.33M |
| Book Value Per Share | 0.46 |
| Working Capital | 79.11M |
Cash Flow
In the last 12 months, operating cash flow was -$49.22 million and capital expenditures -$56,285, giving a free cash flow of -$49.27 million.
| Operating Cash Flow | -49.22M |
| Capital Expenditures | -56,285 |
| Free Cash Flow | -49.27M |
| FCF Per Share | -$1.27 |
Margins
Gross margin is 58.63%, with operating and profit margins of -193.16% and -170.51%.
| Gross Margin | 58.63% |
| Operating Margin | -193.16% |
| Pretax Margin | -195.91% |
| Profit Margin | -170.51% |
| EBITDA Margin | -185.73% |
| EBIT Margin | -187.53% |
| FCF Margin | -153.40% |
Dividends & Yields
SLN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.74% |
| Shareholder Yield | -7.74% |
| Earnings Yield | -5.29% |
| FCF Yield | -4.76% |
Analyst Forecast
The average price target for SLN is $57.25, which is 152.54% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $57.25 |
| Price Target Difference | 152.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SLN has an Altman Z-Score of 1.31 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.31 |
| Piotroski F-Score | 3 |